As a result of the update to the clinical trial protocol for BDC-4182, Bolt now expects to report initial clinical data in the third quarter of 2026. To conserve capital and maintain long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback